| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 2084 |
| 1 | ADALIMUMAB | 2023 |
| 2 | METHOTREXATE | 1850 |
| 3 | ETANERCEPT | 1731 |
| 4 | LEFLUNOMIDE | 1595 |
| 5 | TOCILIZUMAB | 1573 |
| 6 | SULFASALAZINE | 1423 |
| 7 | ABATACEPT | 1361 |
| 8 | TOFACITINIB | 1294 |
| 9 | INFLIXIMAB | 1235 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, CHLORPHENIRAMINE MALEATE | 1 | 0.5000 |
| 1 | TRICLOSAN | 91 | 0.1704 |
| 2 | CAFFEINE CITRATE | 250 | 0.1106 |
| 3 | ZINGIBER OFFICINALE | 7 | 0.0805 |
| 4 | CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE | 51 | 0.0797 |
| 5 | DICLOFENAC POTASSIUM TABLETS | 619 | 0.0739 |
| 6 | CLEAR MINT, GEL TOOTHPASTE | 74 | 0.0694 |
| 7 | SODIUM FLUORIDE F18 | 74 | 0.0688 |
| 8 | SODIUM FLUORIDE F-18 | 74 | 0.0686 |
| 9 | BACITRACIN AND POLYMYXIN B SULFATE | 1 | 0.0667 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 2145 |
| 1 | Folate Analog Metabolic Inhibitor [EPC] | 1849 |
| 2 | Interleukin-6 Receptor Antagonist [EPC] | 1598 |
| 3 | Antirheumatic Agent [EPC] | 1595 |
| 4 | Corticosteroid [EPC] | 1502 |
| 5 | Aminosalicylate [EPC] | 1492 |
| 6 | Selective T Cell Costimulation Modulator [EPC] | 1361 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1317 |
| 8 | CD20-directed Cytolytic Antibody [EPC] | 1236 |
| 9 | Vitamin C [EPC] | 1081 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antirheumatic Agent [EPC] | 1595 | 0.0152 |
| 1 | Endoglycosidase [EPC] | 140 | 0.0137 |
| 2 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 250 | 0.0128 |
| 3 | Interleukin-6 Receptor Antagonist [EPC] | 1598 | 0.0118 |
| 4 | Aminosalicylate [EPC] | 1492 | 0.0113 |
| 5 | Interleukin-6 Antagonist [EPC] | 7 | 0.0111 |
| 6 | Selective T Cell Costimulation Modulator [EPC] | 1361 | 0.0099 |
| 7 | Purine Antimetabolite [EPC] | 814 | 0.0084 |
| 8 | Photoactivated Radical Generator [EPC] | 1 | 0.0081 |
| 9 | Interleukin-12 Antagonist [EPC] | 767 | 0.0075 |